Preclinical safety at tested doses has been reasonable, but human long-term safety data are not established
Section 1833(t)(17)(A) of the Act, which applies to hospitals, as defined under section 1886(d)(1)(B) of the Act, requires that hospitals that fail to report data required for the quality measures selected by the Secretary, in the form and manner required by the Secretary under section 1833(t)(17)(B) of the Act, incur a 2.0 percentage point reduction to their OPD fee schedule increase factor
For women, hormone optimization may involve balancing estrogen, progesterone, or DHEA using bio-identical options tailored to each stage of life
IV therapy is safe, effective and restorative
Future Therapeutic Targets in Rheumatoid Arthritis
Can I take these supplements if Im pregnant or breastfeeding